Ttbio Corp. (TPEX:6493)
Taiwan · Delayed Price · Currency is TWD 52.00
-4.20 (-7.47%)
Jul 9, 2026, 2:51 PM CST
Ttbio Market Cap
Ttbio has a market cap or net worth of 1.56 billion as of July 9, 2026. Its market cap has increased by 271.27% in one year.
Market Cap
1.56B
Enterprise Value
1.68B
Revenue
398.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
52.00
Market Cap Chart
Since January 8, 2015, Ttbio's market cap has increased from 1.19B to 1.56B, an increase of 31.26%. That is a compound annual growth rate of 2.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 1.56B | 91.88% |
| Dec 31, 2025 | 814.36M | 70.16% |
| Dec 30, 2024 | 478.60M | -8.92% |
| Dec 26, 2023 | 525.49M | -19.22% |
| Dec 28, 2022 | 650.55M | 21.30% |
| Dec 30, 2021 | 536.32M | 2.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ICARES Medicus | 3.74B |
| Maxigen Biotech | 3.65B |
| Nang Kuang Pharmaceutical | 3.24B |
| Crystalvue Medical | 1.85B |
| Chi Sheng Pharma & Biotech | 1.82B |
| BenQ Medical Technology | 1.70B |
| Lagis Enterprise | 1.34B |
| Concord Medical | 1.07B |